Annovis Bio
Price & Volume
Stats
See more52W Range | $4.79-$22.49 |
Market Cap | $109.1M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.54 |
News
See moreYahoo Finance • 10 months ago
Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original Projections
Yahoo Finance • 11 months ago
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Yahoo Finance • 12 months ago
Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s Study
Yahoo Finance • last year
Annovis Bio Announces the Filing of a Groundbreaking Patent
About
CEO | Dr. Maria L. Maccecchini Ph.D. |
Address | 101 Lindenwood Drive, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
